Therefore, their treatment is needed for preventing or mitigating complications caused by hormone imbalance such as high blood glucose in diabetics due to insufficient insulin secretion or response [7] and insulin resistance in people with obesity [8, 9] or NAFLD [10]. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.